본문 바로가기
KERD
논문KCI 등재

Inflammatory cytokines in midbrain periaqueductal gray contribute to diabetic induced pain hypersensitivity through phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Background: Diabetes-related neuropathic pain frequently occurs, and the underpinning mechanism remains elusive. The periaqueductal gray (PAG) exhibits descending inhibitory effects on central pain transmission. The current work aimed to examine whether inflammatory cytokines regulate mechanical allodynia and thermal hyperalgesia induced by diabetes through the phosphoinositide 3-kinase (PI3K)-mammalian target of rapamycin (mTOR) pathway in the PAG. Methods: Streptozotocin (STZ) was administered intraperitoneally to mimic allodynia and hyperalgesia evoked by diabetes in rats. Behavioral assays were carried out for determining mechanical pain and thermal hypersensitivity. Immunoblot and ELISA were performed to examine PAG protein amounts of interleukin-1β (IL-1β), IL- 6, and tumor necrosis factor-α (TNF-α), as well as their corresponding receptors in STZ rats, and the expression of PI3K/protein kinase B (Akt)/mTOR signaling effectors. Results: Increased PAG p-PI3K/p-Akt/p-mTOR protein amounts were observed in STZ-induced animals, a PI3K-mTOR pathway inhibition in the PAG attenuated neuropathic pain responses. Moreover, the PAG concentrations of IL-1β, IL-6, and TNF-α and their receptors (namely, IL-1R, IL-6R, and tumor necrosis factor receptor [TNFR] subtype TNFR1, respectively) were increased in the STZ rats. Additionally, inhibiting IL-1R, IL-6R, and TNFR1 ameliorated mechanical allodynia and thermal hyperalgesia in STZ rats, alongside the downregulation of PI3K-mTOR signaling. Conclusions: Overall, the current study suggests that upregulated proinflammatory cytokines and their receptors in the PAG activate PI3K-mTOR signaling, thereby producing a de-inhibition effect on descending pathways in modulating pain transmission, and eventually contributing to neuropathic pain.

Abstract

Background: Diabetes-related neuropathic pain frequently occurs, and the underpinning mechanism remains elusive. The periaqueductal gray (PAG) exhibits descending inhibitory effects on central pain transmission. The current work aimed to examine whether inflammatory cytokines regulate mechanical allodynia and thermal hyperalgesia induced by diabetes through the phosphoinositide 3-kinase (PI3K)-mammalian target of rapamycin (mTOR) pathway in the PAG. Methods: Streptozotocin (STZ) was administered intraperitoneally to mimic allodynia and hyperalgesia evoked by diabetes in rats. Behavioral assays were carried out for determining mechanical pain and thermal hypersensitivity. Immunoblot and ELISA were performed to examine PAG protein amounts of interleukin-1β (IL-1β), IL- 6, and tumor necrosis factor-α (TNF-α), as well as their corresponding receptors in STZ rats, and the expression of PI3K/protein kinase B (Akt)/mTOR signaling effectors. Results: Increased PAG p-PI3K/p-Akt/p-mTOR protein amounts were observed in STZ-induced animals, a PI3K-mTOR pathway inhibition in the PAG attenuated neuropathic pain responses. Moreover, the PAG concentrations of IL-1β, IL-6, and TNF-α and their receptors (namely, IL-1R, IL-6R, and tumor necrosis factor receptor [TNFR] subtype TNFR1, respectively) were increased in the STZ rats. Additionally, inhibiting IL-1R, IL-6R, and TNFR1 ameliorated mechanical allodynia and thermal hyperalgesia in STZ rats, alongside the downregulation of PI3K-mTOR signaling. Conclusions: Overall, the current study suggests that upregulated proinflammatory cytokines and their receptors in the PAG activate PI3K-mTOR signaling, thereby producing a de-inhibition effect on descending pathways in modulating pain transmission, and eventually contributing to neuropathic pain.

참고문헌 (34)

  1. Vinik AI, "Clinical practice. Diabetic sensory and motor neuropathy", N Engl J Med, 374, pp.1455~1464 (2016)
  2. Armstrong DG, "Diabetic foot ulcers and their recurrence", N Engl J Med, 376, pp.2367~2375 (2017)
  3. Ji RR, "Neuroinflammation and central sensitization in chronic and widespread pain", Anesthesiology, 129, pp.343~366 (2018)
  4. Morgado C, "Neuronal hyperactivity at the spinal cord and periaqueductal grey during painful diabetic neuropathy : effects of gabapentin", Eur J Pain, 14, pp.693~699 (2010)
  5. Morgado C, "Changes in serotoninergic and noradrenergic descending pain pathways during painful diabetic neuropathy : the preventive action of IGF1", Neurobiol Dis, 43, pp.275~284 (2011)
  6. Lisi L, "mTOR kinase : a possible pharmacological target in the management of chronic pain", Biomed Res Int, 2015, pp.394257~ (2015)
  7. Santini E, "Mechanisms of translation control underlying long-lasting synaptic plasticity and the consolidation of long-term memory", Prog Mol Biol Transl Sci, 122, pp.131~167 (2014)
  8. Guo JR, "Effect and mechanism of inhibition of PI3K", Akt, Oncotarget, pp.2017, 8[DOI]
  9. Price TJ, "Decreased nociceptive sensitization in mice lacking the fragile X mental retardation protein : role of mGluR1", 5 and mTOR, 2007, pp.27, 13958~13967
  10. Xu Q, "Spinal phosphinositide 3-kinase-Akt-mammalian target of rapamycin signaling cascades in inflammationinduced hyperalgesia", J Neurosci, 31, pp.2113~2124 (2011)
  11. Asante CO, "Formalin-induced behavioural hypersensitivity and neuronal hyperexcitability are mediated by rapid protein synthesis at the spinal level", Mol Pain, 5, pp.27~ (2009)
  12. Zeng H, "mTOR signaling in the differentiation and function of regulatory and effector T cells", Curr Opin Immunol, 46, pp.103~111 (2017)
  13. Li JN, "The central amygdala to periaqueductal gray pathway comprises intrinsically distinct neurons differentially affected in a model of inflammatory pain", J Physiol, 596, pp.6289~6305 (2018)
  14. Mills EP, "Brainstem pain-control circuitry connectivity in chronic neuropathic pain", J Neurosci, 38, pp.465~473 (2018)
  15. Ong WY, "Role of the prefrontal cortex in pain processing", Mol Neurobiol, 56, pp.1137~1166 (2019)
  16. Shabab T, "Neuroinflammation pathways : a general review", Int J Neurosci, 127, pp.624~633 (2017)
  17. Gwak YS, "Neuronal-glial interactions maintain chronic neuropathic pain after spinal cord injury", Neural Plast, 2017, pp.2480689~ (2017)
  18. Yang Y, "Administrations of thalidomide into the rostral ventromedial medulla alleviates painful diabetic neuropathy in Zucker diabetic fatty rats", Brain Res Bull, 125, pp.144~151 (2016)
  19. Goyal SN, "Challenges and issues with streptozotocin-induced diabetes-a clinically relevant animal model to understand the diabetes pathogenesis and evaluate therapeutics", Chem Biol Interact, 244, pp.49~63 (2016)
  20. Swanson LW, "Brain maps 4.0-structure of the rat brain: an open access atlas with global nervous system nomenclature ontology and flatmaps", J Comp Neurol, 526, pp.935~943 (2018)
  21. Um SW, "Pain-relieving effects of mTOR inhibitor in the anterior cingulate cortex of neuropathic rats", Mol Neurobiol, 56, pp.2482~2494 (2019)
  22. Fischer TZ, "Neuropathic pain in diabetes--evidence for a central mechanism", Nat Rev Neurol, 6, pp.462~466 (2010)
  23. Bogush M, "Blood brain barrier injury in diabetes : unrecognized effects on brain and cognition", J Neuroimmune Pharmacol, 12, pp.593~601 (2017)
  24. Benarroch EE, "Periaqueductal gray : an interface for behavioral control", Neurology, 78, pp.210~217 (2012)
  25. Tortorici V, "Comparison of morphine and kainic acid microinjections into identical PAG sites on the activity of RVM neurons", J Neurophysiol, 88, pp.1707~1715 (2002)
  26. Guo J, "Contributions of purinergic P2X3receptors within the midbrain periaqueductal gray to diabetes-induced neuropathic pain", J Physiol Sci, 65, pp.99~104 (2015)
  27. Zhuang X, "Contribution of pro-inflammatory cytokine signaling within midbrain periaqueductal gray to pain sensitivity in Parkinson’s disease via GABAergic pathway", Front Neurol, 7, pp.104~ (2016)
  28. Probert L, "TNF and its receptors in the CNS: the essential, the desirable and the deleterious effects", Neuroscience, 302, pp.2~22 (2015)
  29. Loggia ML, "Evidence for brain glial activation in chronic pain patients", Brain, 138(Pt 3), pp.604~615 (2015)
  30. Tanaka T, "IL-6 in inflammation, immunity, and disease", Cold Spring Harb Perspect Biol, 6, pp.a016295~ (2014)
  31. Hoffman HM, "Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist", Lancet, 364, pp.1779~1785 (2004)
  32. Oka T, "Intracerebroventricular injection of interleukin-1 beta enhances nociceptive neuronal responses of the trigeminal nucleus caudalis in rats", Brain Res, 656, pp.236~244 (1994)
  33. Hahm ET, "GABAergic synaptic response and its opioidergic modulation in periaqueductal gray neurons of rats with neuropathic pain", BMC Neurosci, 12, pp.41~ (2011)
  34. Faraz Mahdian Dehkordi, "The antinociceptive effect of artemisinin on the inflammatorypain and role of GABAergic and opioidergic systems", The Korean Journal of Pain, 32(3), pp.160~167 (2019), 대한통증학회[DOI]

관련 논문AI추천

이 간행물의 다른 논문 (12건)